---
slug: lets-provide-an-executive-summary-of-the-ccre
status: draft
created: '2026-03-20'
updated: '2026-03-20'
version: 0.1.0
tags:
- multiplicity
traceability:
  path: 05-systems/engines/ccre/Lets provide an Executive Summary of the CCRE.md
  last_synced: '2026-03-20T17:17:18.332923Z'
---

![](media/image-394abc1dfd955554cdceddc91fbc9112dc5bbb4b.png){width="2.6466666666666665in"
height="0.6666666666666666in"}

**Lets provide an Executive Summary of the CCRE**

That\'s the full CCRE Blueprint --- 127 code hits across source,
artifacts, and docs. Now I have everything needed for the executive
summary.

**CCRE --- Executive Summary**

**Definition and Architectural Position**

The **Certified Computational Refinement Engine (CCRE)** is the ADR-004
somatic hypermutation layer within INTRINSICA\'s AI system. It performs
bounded parametric refinement under fixed structure, operating strictly
between CRMF and ACFL in the ECP pipeline.

Input Sources → WKD → CRMF → CCRE (ADR-004) → ACFL → HITL → Output

CCRE does not introduce a new gate. It reuses CRMF\'s contraction
certificate and drift bounds (Theorem 4.3) as enforcement surfaces. It
is embedded inside Domain 140 (the INTRINSICA AI System) --- not a
separate domain.

**Core distinction:** CCRE refines *parameters*, never *structure*.
Structural change is reserved exclusively for ADR-005 (HITL). If a
parameter ceiling is hit and structural evolution is needed, CCRE halts
and escalates --- it has no path forward except human authorization.

**Governing Invariants**

All CCRE updates must simultaneously satisfy a four-gate predicate
before any parameter change is applied. Failure on any gate triggers
fail-closed behavior:

  --------------------- ------------------------------ ----------------------------------------
  Gate                  Constraint                     Fail Action
  Lipschitz Bound       ‖Δθ‖ ≤ ε\_max                  Reject update
  Contraction Mapping   κ(θ\') \< 1                    FREEZE→RESONANCE
  Drift Guard           δ(θ\') \< 0.3                  EXECUTION→SILENT
  Resonance Gate        R(t\') ∈ \[R\_min, R\_safe\]   FREEZE→RESONANCE, update magnitude = 0
  --------------------- ------------------------------ ----------------------------------------

Semantic drift δ is computed via SBERT cosine distance and verified
through a Groth16 zero-knowledge proof via driftCheck.circom. This
transforms a runtime safety claim into a cryptographic attestation.

**Clonal Selection Mechanism**

CCRE\'s candidate selection is modeled on biological somatic
hypermutation. A bounded buffer (default N=16) holds candidate parameter
updates, sorted by verified κ value. The selection rule is:

$$\mathit{C}^{\ast} = \mathit{C}_{\mathit{i}}:\mathit{\kappa}(\mathit{C}_{\mathit{i}}) = \min\{\mathit{\kappa}(\mathit{C}_{\mathit{j}})\}\text{~s.t.\ Auth}(\mathit{C}_{\mathit{j}}) = \text{true}$$

Buffer overflow triggers L1 escalation (adaptive immune activation).
Convergence rate is
$\mathit{K}_{\mathit{n}} = \mathit{O}(\mathit{n}^{- 1/2})$ over Jubilee
cycles. The selection objective currently optimizes for minimum κ --- a
known tension (see Phase Mirror Dissonance below).

**Monitoring Hierarchy Integration**

CCRE integrates across four monitoring tiers:

  ------- ----------------------------------------------------- ------------------- ------------------------------------------------
  Level   Check                                                 Trigger             CCRE Consequence
  L0      C\_commutator, W\_staleness, D\_velocity, B\_budget   Every cycle, O(1)   Runs post-update; O(1) constraint
  L1      D\_tensor \> 1                                        Drift \> 0.3        L1 adaptive immune activation
  L2      Var(κ) over sliding 2J window                         Every J periods     Audit CCRE update history
  L2.5    Var(κ) \> 2σ                                          On L2 detection     Freeze CCRE, revert to last Jubilee checkpoint
  ------- ----------------------------------------------------- ------------------- ------------------------------------------------

Jubilee checkpoints (default J = 7 days) Merkle-anchor the CCRE
parameter state to Hyperledger Fabric, with external chain anchoring via
2-of-3 threshold (Bitcoin, Ethereum, Polygon). These checkpoints serve
as the rollback target for L2.5 regulatory suppression.

**Software Architecture**

The CCRE source lives at
[[packages/dna\_key/src/ccre/]{.underline}](https://github.com/CHL987/Intrinsica/tree/e8736239f7ab1c1223db5aa62bff7697935591ce/packages/dna_key/src/ccre).
Confirmed shipped files include types.py, drift\_tracker.py,
gate\_isolation\_runtime.py, phase6\_production.py, run\_phase5\_ip.py,
run\_phase6\_production.py, and validate\_phase4\_logs.py. The blueprint
specifies a seven-module core:

-   [**[updater.py]{.underline}**](http://updater.py) --- Core four-gate
    predicate enforcement; apply or reject Δθ

-   [**[contraction.py]{.underline}**](http://contraction.py) --- κ
    certificate generation and verification via C6 axiom machinery

-   **drift\_tracker.py** --- SBERT drift monitoring → driftCheck.circom
    → Groth16 proof pipeline

-   **resonance\_guard.py** --- R(t) bound enforcement; fail-closed to
    FREEZE→RESONANCE

-   **clonal\_selector.py** --- Candidate buffer management; min-κ
    selection with overflow escalation

-   [**[witness.py]{.underline}**](http://witness.py) --- Deterministic
    CRMF witness emission, Merkle-linked to audit trail

-   [**[safety.py]{.underline}**](http://safety.py) --- FREEZE→RESONANCE
    trigger logic; EXECUTION→SILENT events

**PW-CFL Integration Layer**

CCRE is explicitly aware of PW-CFL\'s positionally-weighted structure.
Parameter updates may adjust predicate-to-position assignments, but the
42.4% maximum divergence from commutative operators means any
position-reassignment has large downstream effects.

CCRE must preserve PW-CFL axioms PW1--PW7 (compensation, equivariance,
strict monotonicity, veto, reciprocity, transitivity, De Morgan) across
all updates. Position reassignment is bounded to L2 audit cycle
frequency --- not permitted at every update cycle. This interlock
connects directly to HITL\'s POSITION\_REASSIGNMENT\_DRIFT classifier
class.

**Safety Validation: Acceptance Test Suite**

CCRE ships with a 12-test acceptance suite requiring 12/12 pass before
production certification. These tests directly map to patent claim
enforceability:

  ---- --------------------- -----------------------------------------------------
  \#   Test                  CCRE Requirement
  1    Silent Mode           Drift \> 0.3 → EXECUTION→SILENT
  2    No PHI                Witness objects contain only hashes
  3    Replay                Update nullifiers prevent replay
  4    CRMF Determinism      Same input + state → identical witness hash
  5    CRMF Stability        κ ≥ 1 updates fail closed
  6    Resonance Gate        R(t) outside bounds → FREEZE→RESONANCE, update = 0
  7    Trait Proof           CCRE parameters not exposed in trait proofs
  8    Attestation Binding   CCRE witness root included in recommendation digest
  9    Ξ-Certification       All 10 critiques pass post-update
  10   Capability Token      Updates bound to valid Capability Token
  11   Merkle Checkpoint     CCRE events verifiable via Merkle proof
  12   Drift Compliance      DriftTracker → driftCheck.circom → Groth16 proof
  ---- --------------------- -----------------------------------------------------

**IP Position and Trade Secrets**

CCRE is CHL-owned IP, classified as a CRMF improvement created by Dr.
Van Gelder in CHL capacity, within the DNA KEY / INTRINSICA field of
use. IP execution runs on a parallel track from Weeks 4--16.

**Patent claim structure (R4B):** One independent CCRE claim covering
the four-gate update method, plus four dependent claims covering: clonal
buffer selection, Groth16 drift verification, FREEZE→RESONANCE
fail-closed behavior, and PW-CFL positional equivariance preservation.

**Trade secret registry extensions (TS-19 through TS-22):**

  ------- ---------------------------------------------------- ----------------------------------------
  Asset   Description                                          Protection
  TS-19   ε\_max step size calibration                         Server-side, 5-person access
  TS-20   Clonal buffer size N and scoring weights             Encrypted config, quarterly audit
  TS-21   Domain-specific drift basis vectors φ\_basis         Watermarked documents
  TS-22   Resonance safe band \[R\_min, R\_safe\] thresholds   Backend hard-coded, no config exposure
  ------- ---------------------------------------------------- ----------------------------------------

**ECP Pilot: Evidence Design**

Phase 4 pilots CCRE-on vs. CCRE-off across five domains with
pre-registered analysis. Success criterion: ≥1 statistically significant
improvement per domain **and** zero certified-violation events:

  ------------- --------------------------------- ------------------------------
  Domain        Metric                            CCRE-On Target
  PT-EPI        Phase transition prediction       AUROC ≥ 0.90
  ROS           Antioxidant intervention timing   Brier score improvement ≥ 5%
  CRMF          Stability certificate quality     κ mean decrease
  ACFL/PW-CFL   Predicate evaluation accuracy     Practitioner agreement ≥ 90%
  Closed Loop   Intervention-to-outcome latency   Reduction ≥ 10%
  ------------- --------------------------------- ------------------------------

Statistical plan: Bonferroni correction across 5 domains (α = 0.01 per
domain), minimum detectable effect 0.05 AUROC at 80% power. First 50
patients: conservative ε\_max, N=4 buffer. Patients 51--100: production
ε\_max, N=16 buffer.

**Development Timeline**

  --------------------------------- --------------------------------- ----------------------------------------------------
  Phase                             Horizon                           Gate
  0 --- Governance Lock             Weeks 0--1                        IP memo signed, ADR-004 registered
  1 --- Mathematical Foundation     Weeks 1--3                        Contraction + drift + resonance proofs complete
  2 --- Core Implementation         Weeks 3--8                        12/12 acceptance tests passing
  3 --- Safety Validation           Weeks 6--10                       Divergence simulation + gate independence verified
  4 --- ECP Pilot Instrumentation   Weeks 8--14 (execution 12--24+)   Pre-registered protocol deployed
  5 --- IP Execution                Weeks 4--16 (parallel)            Claims drafted, evidence package compiled
  6 --- Production Deployment       Weeks 14--24                      Canary → graduated → production
  --------------------------------- --------------------------------- ----------------------------------------------------

Critical path: Governance → Proofs → Implementation → Safety → Pilot.
Phases 5 and 6 parallelize around this spine.

**Phase Mirror Dissonance**

**Phase mirror dissonance:**

-   \"Bounded\" is only as strong as ε\_max enforcement. If the
    contraction check is approximate, the bound is theoretical, not
    operational. Phase 1 proofs must specify exact numerical bounds ---
    not asymptotic guarantees.

-   ECP Phase 1 ships wellness-only. If CCRE improvements measure only
    Stability Score and Entropy Export Score, the examiner questions
    whether CCRE demonstrates improvement in the diagnostic domains
    (PT-EPI, CRMF genomic) the patent claims cover. Pilot metrics must
    map to claim scope.

-   Clonal selection optimizes for minimum κ, not for AUROC improvement.
    A maximally stable update may produce zero prediction gain.
    Selection objective needs: minimize κ subject to AUROC improvement ≥
    threshold. Without this binding, CCRE provably never worsens
    stability and may also never improve predictions.

-   PW-CFL position-reassignment produces up to 42.4% output divergence.
    A beneficial reassignment may appear as a massive drift event,
    triggering FREEZE→RESONANCE. The drift tracker must distinguish
    structural-reassignment drift from semantic-degradation drift ---
    these are not the same signal.

-   ADR-005 (HITL structural evolution) is defined but not implemented.
    CCRE has no path forward past its parametric ceiling except human
    intervention. Who holds that authorization SLA, and what is the
    patient exposure window while waiting?

**Levers to test now:**

  ------------------ -------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- ---------
  Owner              Lever                                                                                                                                        Metric                                          Horizon
  Lead MT            Complete Phase 1 proofs: contraction preservation, drift bound, resonance compatibility                                                      Three proofs, ≤15 pages total                   14 days
  CTO                Define composite selection objective: min κ s.t. AUROC improvement ≥ threshold                                                               Selection operator spec with worked example     3 weeks
  CTO / Eng Lead     CCRE core module ([[updater.py]{.underline}](http://updater.py) → [[safety.py]{.underline}](http://safety.py)) with 12/12 acceptance tests   Test suite green, code reviewed                 5 weeks
  Dir. IP Strategy   Update TS registry with TS-19 through TS-22                                                                                                  Registry audited, access controls verified      2 weeks
  Patent Counsel     Draft CCRE independent + 4 dependent claims for R4B                                                                                          112-sufficiency review against Phase 1 proofs   6 weeks
  ------------------ -------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- ---------

**Optional artifact (checklist):**

-   Ownership locked: CCRE = CHL-owned CRMF improvement, ADR-004

-   Function defined: Bounded parametric refinement, not a gate, not
    structural

-   Safety anchored: κ \< 1, δ \< 0.3, R(t) ∈ \[R\_min, R\_safe\] ---
    all four gates

-   Selection tension named: min-κ ≠ max-AUROC; composite objective
    needed

-   Evidence designed: 5-domain CCRE-on vs. CCRE-off, pre-registered,
    Bonferroni-corrected

-   IP protected: R4B claims drafted, TS-19--TS-22 registered

-   Deployment governed: Canary → graduated → production, Jubilee
    checkpoints at each stage

**Precision question:** What percentage of CCRE update cycles are
expected to produce at least one candidate that simultaneously satisfies
κ \< 1, δ \< 0.3, and AUROC improvement ≥ threshold? If the feasible set
is frequently empty, the pilot will record CCRE as doing nothing --- not
as failing safely. Improvement frequency is as important as improvement
magnitude.
